BlackRock, Inc.

Position in ALXO — Alx Oncology Holdings Inc

CIK 2012383 New York, NY

Position in ALXO

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$15,317,024

+$14,419,189 QoQ

Shares Held

7,399,530

+1552.4% QoQ

Ownership

5.35%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 94 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 98% Shared 0% None 2%

Healthcare · as of Jun 30, 2026

BlackRock, Inc. holds $85,016,936,299 across 474 Biotechnology names. ALXO ranks #248 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	24,109,373	$11,975,848,839
2	REGN	Regeneron Pharmaceuticals, Inc.	9,113,506	$5,682,635,520
3	ALNY	Alnylam Pharmaceuticals, Inc.	10,907,675	$3,283,537,392
4	RVMD	Revolution Medicines, Inc.	13,695,790	$2,564,947,540
5	MRNA	Moderna, Inc.	30,599,409	$2,142,876,602
6	INCY	Incyte Corp	18,032,718	$2,044,188,902
7	CYTK	Cytokinetics Inc	20,094,362	$1,711,838,691
8	ROIV	Roivant Sciences Ltd.	48,236,091	$1,707,075,250

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,168,649	7,327,850	—	Shares	Sole	2026-07-27
2026-06-30	$15,317,024	7,399,530	+1552.4%	Shares	Sole	2026-08-07
2026-03-31	$897,835	447,799	-0.6%	Shares	Sole	2026-05-13
2025-12-31	$508,983	450,430	+0.6%	Shares	Sole	2026-02-12
2025-09-30	$819,273	447,692	-37.5%	Shares	Sole	2025-11-12
2025-06-30	$297,261	716,297	-69.0%	Shares	Sole	2025-08-12
2025-03-31	$1,441,494	2,313,800	-3.0%	Shares	Sole	2025-05-02
2024-12-31	$3,981,690	2,384,247	-8.4%	Shares	Sole	2025-02-07
2024-09-30	$4,735,229	2,601,776	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.